Compare PRTA & JBSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRTA | JBSS |
|---|---|---|
| Founded | 2012 | 1959 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 458.4M | 846.7M |
| IPO Year | 2013 | 1994 |
| Metric | PRTA | JBSS |
|---|---|---|
| Price | $8.54 | $66.48 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 2 |
| Target Price | $21.40 | ★ $100.00 |
| AVG Volume (30 Days) | ★ 337.4K | 77.2K |
| Earning Date | 11-05-2026 | 10-28-2026 |
| Dividend Yield | N/A | ★ 6.77% |
| EPS Growth | N/A | ★ 4.57 |
| EPS | 0.26 | ★ 5.26 |
| Revenue | $814,000.00 | ★ $1,175,673,000.00 |
| Revenue This Year | $758.69 | $0.97 |
| Revenue Next Year | N/A | $3.63 |
| P/E Ratio | $33.27 | ★ $12.88 |
| Revenue Growth | N/A | ★ 6.18 |
| 52 Week Low | $7.73 | $59.07 |
| 52 Week High | $11.80 | $92.08 |
| Indicator | PRTA | JBSS |
|---|---|---|
| Relative Strength Index (RSI) | 44.91 | 29.93 |
| Support Level | $8.12 | N/A |
| Resistance Level | $9.29 | $84.75 |
| Average True Range (ATR) | 0.38 | 1.54 |
| MACD | -0.02 | 0.29 |
| Stochastic Oscillator | 41.50 | 11.37 |
Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. Prothena is developing and applying its proprietary CYTOPE technology to target a broad spectrum of intracellular disease pathways in the brain and periphery. The company's pipeline includes both wholly-owned and partnered programs like Prasinezumab, Coramitug (PRX004), BMS-986446 (PRX005), PRX019, TDP-43 CYTOPE, and PRX012-TfR, being developed for the potential treatment of Parkinson's disease, ATTR amyloidosis with cardiomyopathy, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases.
John B Sanfilippo & Son Inc is processors and distributors of peanuts, pecans, cashews, walnuts, almonds and other nuts in the United States. It also manufacture and distribute a portfolio of snack and nutrition bars, and market and distribute, and in some cases, manufacture or process, a diverse product line of other food and snack products, including peanut butter, almond butter, cashew butter, candy and confections, snack and trail mixes, granola, sunflower kernels, dried fruit, corn snacks, sesame sticks and other sesame snack products. It mainly sell its products under a variety of private brand names, as well as under its Fisher, Orchard Valley Harvest, Squirrel Brand and Southern Style Nuts brand names. It operate in a single reporting segment.